Atomically Precise Fluorescent Gold Nanocluster as a Barrier-Permeable and Brain-Specific Imaging Probe
Lakshmi V Nair1,2, Resmi V Nair1,3, Bilal Ahmad Lone1
1Division of Biophotonics and Imaging, Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST), Trivandrum, 695012, India.
Chemistry, an Asian Journal
|October 9, 2024
Summary
Researchers developed L-dopa-conjugated gold clusters (Dop@LAuC) to overcome the blood-brain barrier (BBB) for optical brain imaging. This targeted nanomaterial effectively crosses the BBB, enabling enhanced early diagnosis of brain disorders.
Area of Science:
- Nanomaterials Science
- Biomedical Imaging
- Neuroscience
Background:
- Photonic nanomaterials are vital for optical brain imaging, aiding early diagnosis of brain disorders.
- The blood-brain barrier (BBB) restricts the passage of most substances into the brain, posing a challenge for imaging agents.
Purpose of the Study:
- To develop a targeted nanomaterial capable of crossing the BBB for enhanced optical brain imaging.
- To evaluate the efficacy of L-dopa-conjugated gold clusters (Dop@LAuC) in penetrating the BBB.
Main Methods:
- Synthesis of gold clusters (LAuC) and conjugation with Levodopa to form Dop@LAuC.
- In vitro assessment of Dop@LAuC and LAuC penetration across a BBB model using brain endothelial cells.
- In vivo optical imaging in mice to confirm BBB crossing and assess barrier integrity.
Main Results:
- Dop@LAuC demonstrated significantly enhanced BBB penetration (50% in 3 hours) compared to unconjugated LAuC (10% in 3 hours) in vitro.
- In vivo imaging confirmed that Dop@LAuC effectively crosses the BBB without compromising its integrity.
- The nanomaterial emits in the near-infrared (NIR) spectrum, suitable for real-time optical imaging.
Conclusions:
- Levodopa conjugation enhances the ability of gold clusters to cross the blood-brain barrier.
- Dop@LAuC represents a promising tool for targeted optical brain imaging and early disease diagnosis.
- This approach offers a potential strategy to overcome BBB limitations in neuroimaging.


